Comments
Loading...

Allogene Therapeutics Inc (ALLO) Stock Price, Quote, News & History

ALLONASDAQ
$1.80
0.1811.11%
At close: Feb 13, 4:00 PM EST
$1.80
N/A
After Hours: 6:59 PM EST

Key Statistics

Open
$1.63
Close
$1.80
Volume / Avg.
4.71M / 4.16M
Day Range
$1.63 - $1.83
52 Wk Range
0.86 - 3.78
Market Cap
$404.51M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
58
Short Interest
10.08%
Days to Cover
2.59

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-158.35M
Investing Cash Flow (TTM)
116.88M
Financing Cash Flow (TTM)
28.04M
Free Cash Flow (TTM)
-158.99M
Capital Expenditure (TTM)
-643.00K
Net Change in Cash (TTM)
-13.42M

Analyst Trends and Forecast

1
Oct 25
1
Jan
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.8
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$204.73M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
1.16
Earnings Yield % (TTM)
-60.31%
Earnings Yield % (FWD)
-68.00%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$1.40

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$37.82M
Debt to Equity
0.24
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$1.63
Close
$1.80
Volume / Avg.
4.71M / 4.16M
Day Range
$1.63 - $1.83
52 Wk Range
0.86 - 3.78
Market Cap
$404.51M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
58
Short Interest
10.08%
Days to Cover
2.59

About

Sector
Health Care
Industry
Biotechnology
Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-c...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ALLO
ZURA

FAQ

Q

How do I buy Allogene Therapeutics (ALLO) stock?

A

You can purchase shares of Allogene Therapeutics (NASDAQ:ALLO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Allogene Therapeutics (ALLO) competitors?

Q

What is the forecast, or price target, for Allogene Therapeutics (ALLO) stock?

A

Allogene Therapeutics has a consensus price target of $10.09.

Q

What is the current price for Allogene Therapeutics (ALLO)?

A

The stock price for Allogene Therapeutics (NASDAQ: ALLO) is $1.8 last updated February 13, 2026 at 6:59 PM EST.

Q

Does Allogene Therapeutics (ALLO) pay a dividend?

A

There are no upcoming dividends for Allogene Therapeutics.

Q

When is Allogene Therapeutics (NASDAQ:ALLO) reporting earnings?

A

Allogene Therapeutics does not have any upcoming earnings scheduled.

Q

Is Allogene Therapeutics (ALLO) going to split?

A

There is no upcoming split for Allogene Therapeutics.

Q

What sector and industry does Allogene Therapeutics (ALLO) operate in?

A

Allogene Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.